Watson gets FDA approval for generic asthma drug – Businessweek

Watson gets FDA approval for generic asthma drug
Businessweek
PARSIPPANY, N.J. (AP) — Generic drugmaker Watson Pharmaceuticals Inc. said Wednesday it received U.S. approval for its generic version of Pulmicort, an inhalable drug used to treat cough and breathing problems caused by asthma and lung disease.
FDA approves Watson asthma genericDrug Store News
Watson's Generic Version of Pulmicort RESPULES® Receives FDA ApprovalMarketWatch (press release)

all 13 news articles »

View full post on asthma – Google News